NIH Team Identifies Genomic Signature Shared by Five Types of Cancer
Researchers hope to spur development of a blood test that can be used to diagnose a variety of cancers at early stages.
Read More
Search Results for: prostate cancer
GenomeDx Launches Genomic Test for Prostate Cancer
The launch brings the Decipher prostate cancer classifier, already clinically adopted and extensively validated for use following surgery, to newly diagnosed patients at initial biopsy.
Read More
Arquer Diagnostics to Bolster Study Data Supporting Bladder Cancer Test
The company recently received ethical approval to commence a 6-month clinical study using its urine test for cancer.
Read MoreAnalysis of Prostate Cancer Biopsies Validated to Predict Metastasis
GenomeDx Biosciences recently presented first validation data supporting the use of its Decipher test to help guide the treatment of men newly diagnosed with prostate cancer.
Read MorePartners Eye Companion Diagnostics Market
Under a new collaboration agreement, NanoString will modify its PAM50-based Prosigna breast cancer assay for potential use as a companion diagnostic for enzalutamide treatment of triple-negative breast cancer.
Read More